Clinical Trial Update: A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing add-on sulforaphane or rTMS to escitalopram for major depressive disorder with poor initial treatment response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)
• RTMS (Repetitive transcranial magnetic stimulation)
• Sulforaphane (sulforaphane)

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Major Depressive Disorder | Phase 4 | Status: UNKNOWN